Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
25149 | Safusidenib | 1898206-17-1 | ≧98.0% | ![]() |
Safusidenib, also known as DS-1001, is an oral isocitrate dehydrogenase [NADP] cytopl | ||||
25117 | Sepiapterin | 17094-01-8 | 98% Min. | ![]() |
Sepiapterin is a tetrahydrobiopterin (BH4) precursor. | ||||
25107 | Sovleplenib | 1415792-84-5 | 98% Min. | ![]() |
Sovleplenib is a tyrosine kinase inhibitor. It is also an antineoplastic agent. | ||||
25087 | SUVN-G3031 HCl | 1394808-20-8 | 98% Min. | ![]() |
SUVN-G3031 is a Histamine H3 receptor antagonist, which is potentially useful for tre | ||||
25079 | Sevabertinib ( BAY-2927088 ) | 2521285-05-0 | ≧98.0% | ![]() |
Sevabertinib ( BAY-2927088 ) is a oral, non-covalent, tyrosine kinase receptor inhibi | ||||
25066 | SPB linker | 858128-57-1 | 98% Min. | ![]() |
SPB is a agent-linker conjugate for ADC with potent anti-inflammatory activity by usi | ||||
25063 | Seladelpar sodium salt | 3026272-26-1 | ≧98.0% | ![]() |
Seladelpar is a PPAR-delta agonist. | ||||
25059 | SDU-071 | 3036109-10-8 | 98% Min. | ![]() |
SDU-071 is a potent and orally active inhibitor of BRD4-p53 inhibitor. SDU-071 suppre | ||||
25053 | SABA1 | 690681-65-3 | 98% Min. | ![]() |
SABA1 is an antibacterial agent against Pseudomonas aeruginosa and Escherichia coli. | ||||
25043 | Survodutide | 2805997-46-8 | 98% Min. | |
24153 | SR-11302 | 160162-42-5 | 98% Min. | ![]() |
SR 11302 is an activator protein-1 (AP-1) transcription factor inhibitor. | ||||
24142 | Stafib-2 | 2097938-74-2 | 98% Min. | ![]() |
Stafib-2 is a potent and selctive inhibitor of the transcription factor STAT5b, with | ||||
24137 | SR 16584 | 1150153-86-8 | 98% Min. | ![]() |
SR 16584 is an antagonist of the α3β4 nAChR subtype (IC50 = 10.2 μM). | ||||
24119 | Sepetaprost | 1262873-06-2 | 98% Min. | ![]() |
Sepetaprost is a prodrug of ONO-AG-367. It has been used in trials studying the treat | ||||
24106 | SB-202190 | 152121-30-7 | 98% Min. | ![]() |
SB-202190 is a highly selective, potent and cell-permeable inhibitor of p38 MAP kinas | ||||
24100 | Saruparib | 2589531-76-8 | 98% Min. | ![]() |
Saruparib, also known as AZD5305 is a potent, selective and oral active PARP inhibito | ||||
24090 | SMU-L11 | 3029695-07-3 | 98% Min. | ![]() |
24082 | SX-682 | 1648843-04-2 | 98% Min. | ![]() |
SX-682 is a potent and selective Cxcr1/2 inhibitor potentially useful for castration- | ||||
24065 | SPG-302 | 2274723-90-7 | 98% Min. | ![]() |
Phenylbenzothiazole-PEG4-OH (compound 1) can treat spinal cord injury and promote spi | ||||
24049 | (S)-Colchicine | 64-86-8 | 98% Min. | ![]() |
(S)-Colchicine is a medication most commonly used to treat gout. Colchicine inhibits | ||||
24048 | Sebetralstat free base | 1933514-13-6 | 98% Min. | ![]() |
Sebetralstat (KVD-900), an oral plasma kallikrein inhibitor. | ||||
24042 | SPG-601 ( VSN-16R ) | 863713-78-4 | ≧98.0% | ![]() |
SPG-601 (formerly VSN-16R) is an orally available cannabinoid receptor agonist. | ||||
24016 | SY-008 Acetate | 1878218-66-6 | ≧98.0% | ![]() |
SY-008 is a sodium glucose transporter 1 (SGLT1) inhibitor. | ||||
24021 | SY-008 | 1480443-32-0 | ≧98.0% | ![]() |
SY-008 is a sodium glucose transporter 1 (SGLT1) inhibitor. | ||||
24019 | (S)-3-amino-3-(4-chlorophenyl)propan-1-ol | 886061-26-3 | ≧98.0% | ![]() |
20671 | Soquelitinib ( CPI-818 ) | 2226636-04-8 | 98.0% | ![]() |
Soquelitinib is an oral interleukin-2-inducible T cell kinase (ITK) inhibitor. | ||||
20663 | Sotuletinib HCl | 2222138-31-8 (HCl) | 98% Min. | |
Sotuletinib, also known as BLZ945, is a potent and selective CSF-1R kinase inhibitor. | ||||
20662 | SKF-91488 HCl | 68941-21-9 | 98% Min. | ![]() |
SKF 91488 dihydrochloride is a homolog of dimaprit. | ||||
20650 | Sonrotoclax (BGB-11417) | 2383086-06-2 | ≧98.0% | ![]() |
Sonrotoclax is an antineoplastic. | ||||
20639 | SOP1812 (QN-302) | 2546091-70-5 | ≧98.0% | ![]() |
QN-302 is a G-quadruplex (G4)-selective transcription inhibitor. |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2025 Wuhan Sun-shine Bio-technology Corporation Limited. | 鄂ICP备17005301号-1